Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

Susan J Ramus; Honglin Song; Ed Dicks; Jonathan P Tyrer; Adam N Rosenthal; Maria P Intermaggio; Lindsay Fraser; Aleksandra Gentry-Maharaj; Jane Hayward; Susan Philpott; Christopher Anderson; Christopher K Edlund; David Conti; Patricia Harrington; Daniel Barrowdale; David D Bowtell; Kathryn Alsop; Gillian Mitchell; Mine S Cicek; Julie M Cunningham; Brooke L Fridley; Jennifer Alsop; Mercedes Jimenez-Linan; Samantha Poblete; Shashi Lele; Lara Sucheston-Campbell; Kirsten B Moysich; Weiva Sieh; Valerie McGuire; Jenny Lester; Natalia Bogdanova; Matthias Duerst; Peter Hillemanns; Kunle Odunsi; Alice S Whittemore; Beth Y Karlan; Thilo Doerk; Ellen L Goode; Usha Menon; Ian J Jacobs; Antonis C Antoniou; Paul DP Pharoah; Simon A Gayther

Journal article

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott, Christopher Anderson, Christopher K Edlund, David Conti, Patricia Harrington, Daniel Barrowdale, David D Bowtell, Kathryn Alsop, Gillian Mitchell, Mine S Cicek, Julie M Cunningham Show all

JNCI: Journal of the National Cancer Institute | OXFORD UNIV PRESS INC | Published : 2015

DOI: 10.1093/jnci/djv214

University of Melbourne Researchers

Gillian Mitchell Author The Sir Peter MacCallum Department of Oncology

David Bowtell Author The Sir Peter MacCallum Department of Oncology

Grants

Awarded by Cancer Research UK

Awarded by National Institutes for Health

Awarded by National Health & Medical Research Council of Australia (NHMRC)

Awarded by Cancer Australia

Awarded by US Army Medical Research and Materiel Command

Awarded by National Cancer Institute

Awarded by The Francis Crick Institute

Awarded by NATIONAL CANCER INSTITUTE

Funding Acknowledgements

This work was funded by the Cancer Councils of New South Wales, Victoria, Queensland, South Australia, and Tasmania, the Cancer Foundation of Western Australia, Cancer Research UK (C1005/A7749, C315/A2621, C490/A10119, C490/A10124, C490/A16561, C1005/A12677, C1005/A6383), the Eve Appeal (The Oak Foundation), the Fred C. and Katherine B. Andersen Foundation, the National Institutes for Health (P30 CA016056, P30-CA15083, P50CA136393, P50CA159981, R01CA122443, R01CA178535, R01CA61107, R01CA152990, and R01CA086381), the National Health & Medical Research Council of Australia (NHMRC; ID400413, ID400281), Cancer Australia (509303), Roswell Park Cancer Institute Alliance Foundation, the UK Department of Health, the UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge and University College London Hospitals Biomedical Research Centre, and the US Army Medical Research and Materiel Command (DAMD17-01-1-0729; W81XWH-08-1-0684 and W81XWH-08-1-0685). The project described was also supported in part by award number P30CA014089 from the National Cancer Institute.